Dashboard
Manage Tickers

CNMD CONMED Corp

NYSE conmed.com


$ 44.20 $ -0.23 (-0.52 %)    

Thursday, 06-Nov-2025 15:59:59 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.31 $ -11.61 (-1.86 %)
DIA $ 469.50 $ -3.83 (-0.81 %)
SPY $ 671.30 $ -7.27 (-1.07 %)
TLT $ 89.70 $ 0.80 (0.9 %)
GLD $ 365.69 $ -0.44 (-0.12 %)
$ 44.21
$ 45.19
$ 42.50 x 10
$ 48.19 x 1
$ 41.62 - $ 45.19
$ 41.62 - $ 76.94
848,511
na
1.37B
$ 1.00
$ 21.37
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 07-31-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-18-2025 12-31-2024 10-K
5 10-31-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 04-25-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 10-26-2023 09-30-2023 10-Q
10 07-27-2023 06-30-2023 10-Q
11 04-27-2023 03-31-2023 10-Q
12 02-21-2023 12-31-2022 10-K
13 10-27-2022 09-30-2022 10-Q
14 07-28-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-22-2022 12-31-2021 10-K
17 10-28-2021 09-30-2021 10-Q
18 07-29-2021 06-30-2021 10-Q
19 04-29-2021 03-31-2021 10-Q
20 02-22-2021 12-31-2020 10-K
21 10-29-2020 09-30-2020 10-Q
22 07-30-2020 06-30-2020 10-Q
23 04-30-2020 03-31-2020 10-Q
24 02-24-2020 12-31-2019 10-K
25 10-31-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 04-26-2019 03-31-2019 10-Q
28 02-25-2019 12-31-2018 10-K
29 11-02-2018 09-30-2018 10-Q
30 08-02-2018 06-30-2018 10-Q
31 04-26-2018 03-31-2018 10-Q
32 02-26-2018 12-31-2017 10-K
33 11-02-2017 09-30-2017 10-Q
34 07-27-2017 06-30-2017 10-Q
35 04-27-2017 03-31-2017 10-Q
36 02-27-2017 12-31-2016 10-K
37 10-28-2016 09-30-2016 10-Q
38 07-28-2016 06-30-2016 10-Q
39 05-02-2016 03-31-2016 10-Q
40 02-23-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-neutral-on-conmed-lowers-price-target-to-52
JP Morgan Maintains Neutral on Conmed, Low...
11/06/2025 22:16:29

JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Neutral and lowers the price target from $58 to $52.

piper-sandler-maintains-overweight-on-conmed-lowers-price-target-to-55
Piper Sandler Maintains Overweight on Conm...
11/06/2025 16:09:34

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $68 t...

wells-fargo-maintains-equal-weight-on-conmed-lowers-price-target-to-47
Wells Fargo Maintains Equal-Weight on Conm...
11/06/2025 15:46:01

Wells Fargo analyst Vik Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $57 to $47.

conmed-narrows-fy2025-adj-eps-guidance-from-440-455-to-448-453-vs-447-est-narrows-fy2025-sales-guidance-from-1356b-1378b-to-1365b-1372b-vs-1368b-est
Conmed Narrows FY2025 Adj EPS Guidance fro...
11/05/2025 21:29:35

Conmed (NYSE:CNMD) narrows FY2025 Adj EPS guidance from $4.40-$4.55 to $4.48-$4.53 vs $4.47 analyst estimate. Narrows FY2025 sa...

conmed-q3-adj-eps-108-beats-105-estimate-sales-337900m-beat-334760m-estimate
Conmed Q3 Adj. EPS $1.08 Beats $1.05 Estim...
11/05/2025 21:28:38

Conmed (NYSE:CNMD) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $1.05 by 2.66 pe...

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

piper-sandler-maintains-overweight-on-conmed-lowers-price-target-to-68
Piper Sandler Maintains Overweight on Conm...
07/31/2025 13:55:51

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $80 t...

conmed-lowers-fy2025-adj-eps-guidance-from-445-460-to-440-455-vs-439-est-raises-fy2025-sales-guidance-from-1350b-1378b-to-1356b-1378b-vs-1362b-est
Conmed Lowers FY2025 Adj EPS Guidance from...
07/30/2025 21:05:34

Conmed (NYSE:CNMD) lowers FY2025 Adj EPS guidance from $4.45-$4.60 to $4.40-$4.55 vs $4.39 analyst estimate. Raises FY2025 sale...

conmed-q2-adj-eps-115-beats-112-estimate-sales-342345m-beat-338167m-estimate
Conmed Q2 Adj. EPS $1.15 Beats $1.12 Estim...
07/30/2025 20:06:39

Conmed (NYSE:CNMD) reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $1.12 by 2.4 per...

Core News & Articles
Earnings Scheduled For July 30, 2025
07/30/2025 08:32:48

merit-medical-names-medtronic-veteran-martha-aronson-as-next-ceo-projects-strong-outlook
Merit Medical Names Medtronic Veteran Mart...
07/08/2025 12:34:54

Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates.

this-conagra-brands-analyst-turns-bearish-here-are-top-3-downgrades-for-thursday
This Conagra Brands Analyst Turns Bearish;...
06/12/2025 13:10:43

demystifying-conmed-insights-from-5-analyst-reviews
Demystifying Conmed: Insights From 5 Analy...
06/12/2025 13:00:48

needham-downgrades-conmed-to-hold-maintains-price-target-to-61
Needham Downgrades Conmed to Hold, Maintai...
06/12/2025 12:32:17

Needham analyst Mike Matson downgrades Conmed (NYSE:CNMD) from Buy to Hold and maintains the price target from $61 to $61.

conmed-appoints-laverne-council-to-succeed-martha-goldberg-aronson-as-independent-chair-of-the-board-of-directors-effective-may-21-2025
CONMED Appoints Laverne Council To Succeed...
05/21/2025 11:17:53

jp-morgan-maintains-neutral-on-conmed-lowers-price-target-to-58
JP Morgan Maintains Neutral on Conmed, Low...
05/01/2025 17:47:44

JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Neutral and lowers the price target from $70 to $58.

cvs-health-posts-better-than-expected-earnings-joins-commscope-microsoft-meta-chart-industries-and-other-big-stocks-moving-higher-on-thursday
CVS Health Posts Better-Than-Expected Earn...
05/01/2025 15:36:36

wells-fargo-maintains-equal-weight-on-conmed-lowers-price-target-to-57
Wells Fargo Maintains Equal-Weight on Conm...
05/01/2025 15:28:35

Wells Fargo analyst Vik Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $70 to $57.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/01/2025 12:05:58

breaking-down-conmed-6-analysts-share-their-views
Breaking Down Conmed: 6 Analysts Share The...
05/01/2025 12:00:33

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION